The FIBRO System: A rapid strategy for assessment and management of fibromyalgia syndrome

Therapeutic Advances in Musculoskeletal Disease

Volumn 2, Issue 4, 2010, Pages 187-200

  Boomershine, Chad S ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

adverse effects; exercise; fibromyalgia; outcome assessment; review; therapeutics

Indexed keywords

EID: 84993790846     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X10374437     Document Type: Article

References (90)

1. Arnold, L.M., Hess, E.V., Hudson, J.I., Welge, J.A., Berno, S.E. and Keck Jr, P.E. ( 2002) A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112: 191-197.
2. Arnold, L.M., Goldenberg, D.L., Stanford, S.B., Lalonde, J.K., Sandhu, H.S., Keck Jr, P.E. et al. (2007) Gabapentin in the treatment of fibromyalgia. Arthritis Rheum 56: 13360-13444
3. Bennett, R. ( 2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheum 23(Suppl 39): S154-S162.
4. Bennett, R.M., Friend, R., Jones, K.D., Ward, R., Han, B.K. and Ross, R.L. ( 2009) The Revised Fibromyalgia Impact Questionnaire (FIQR). Arthritis Res Therapy 11: R120, Available at: http://arthritis-research.com/content/11/4/R120 (accessed 4 April 2010).
5. Bennett, R.M., Schein, J., Kosinski, M.R., Hewitt, D.J., Jordan, D.M. and Rosenthal, N.R. ( 2005) Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 53: 519-527.
6. Boomershine, C.S. ( 2010) Pregabalin for the management of fibromyalgia syndrome. J Pain Res 3: 1-8.
7. Boomershine, C.S. and Crofford, L.J. (2009) A symptom-based approach to pharmacologic management of fibromyalgia. Nature Rev Rheumatol 5: 191-199.
8. Boomershine, C.S., Titova, D., Chung, C.P., Oeser, A. and Stein, M. ( 2008) Five visual analogue scales quantify global disease severity and identify clinically significant symptoms in fibromyalgia syndrome. Arthritis Rheum 58: S686-S687.
9. Buskila, D. ( 2009) Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther 11: 242, Available at: http://arthritis-research.160com/content/11/5/242 (accessed 14 April 2010).
10. Carville, S.F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J.C., Buskila, D. et al. (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67: 536-541.
11. Cephalon (2008). Amrix prescribing information. Available at: http://www.amrix.com/hcp/default.aspx (accessed 14 April 2010).
12. Cephalon (2010). Nuvigil prescribing information. Available at: http://www.nuvigil.com/media/Full_Prescribing_Information.pdf (accessed 14 April 2010).
13. Cicero, T.J., Adams, E.H., Geller, A., Inciardi, J.A., Munoz, A., Schnoll, S.H. et al. (1999) A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 57: 7-22.
14. Clauw, D. ( 2008) Pharmacotherapy for patients with fibromyalgia. J Clin Psychiat 69(Suppl 2): 25-30.
15. Cleeland, C.S. ( 1989) Measurement of pain by subjective report, In: Chapman, C.R. and Loeser, J.D. (eds). Issues in Pain Measurement (Advances in Pain Research and Therapy, Vol.12), Raven Press: New York, pp. 391-403.
16. Cohrs, S., Rodenbeck, A., Guan, Z., Pohlmann, K., Jordan, W., Meier, A. et al. (2007) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 174: 421-429.
17. Culpepper, L. and Mattingly, G. ( 2008) A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgrad Med 120: 16-26.
18. Eli Lilly and Company (2010). Cymbalta prescribing information. Available at: http://pi.lilly.com/us/cymbalta-pi.pdf (accessed 14 April 2010 ).
19. Farias, S.T., Mungas, D., Reed, B.R., Cahn-Weiner, D., Jagust, W., Baynes, K. et al. (2008) The measurement of everyday cognition (ECog). Neuropsychology 22: 531-544.
20. Farrar, J.T., Young Jr, J.P., LaMoreaux, L., Werth, J.L. and Poole, R.M. ( 2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94: 149-158.
21. Forest Pharmaceuticals Inc. (2009). Savella prescribing information. Available at: http://www.frx.com/pi/Savella_pi.pdf (accessed 14 April 2010).
22. Glass, J.M. ( 2008) Fibromyalgia and cognition. J Clin Psychiatry 69(Suppl 2): 20-24.
23. Goldenberg, D., Mayskiy, M., Mossey, C., Ruthazer, R. and Schmid, C. ( 1996) A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39: 1852-1859.
24. Graudins, A., Aaron, C.K. and Linden, C.H. ( 1995) Overdose of extended-release acetaminophen. N Engl J Med 33: 196.
25. Guy, W. (ed.) (1976) ECDEU Assessment Manual for Psychopharmacology, Revised. Publication Adm 76-338. Washington, DC: US Department of Health, Education, and Welfare.
26. Harris, R.E., Sundgren, P.C., Craig, A.D., Kirshenbaum, E., Sen, A., Napadow, V. et al. (2009) Elevated Insular Glutamate in Fibromyalgia is Associated with Experimental Pain. Arthritis Rheum 60 (10): 3146-3152.
27. Hidalgo, J., Rico-Villademoros, F. and Calandre, E.P. ( 2007) An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 31: 71-77.
28. Hindmarch, I. ( 2005) A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 28: 187-193.
29. Hindmarch, I., Dawson, J. and Stanley, N. ( 2005) A double blind study in healthy volunteers to assess the effects of sleep of pregabalin compared with alprazolam and placebo. Sleep 28: 187-193.
30. Hirschfeld, R., Williams, J., Spitzer, R., Calabrese, J.R., Flynn, L., Keck, P.E. et al. (2000) Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. Am J Psychiatry 157: 1873-1875.
31. Holman, A.J. ( 2003) Ropinirole, open preliminary observations of a dopamine agonist for refractory fibromyalgia. J Clin Rheum 9: 277-279.
32. Holman, A.J. and Myers, R.R. ( 2005) A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52: 2495-2505.
33. Katz, R.S., Wolfe, F. and Michaud, K. ( 2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arth Rheum 54: 169-176.
34. Kroenke, K., Spitzer, R.L. and Williams, J.B.W. ( 2001) The PHQ-9. J Gen Med 16: 606-613.
35. Krupp, L.B., LaRocca, N.G., Muir-Nash, J. and Steinberg, A.D. ( 1989) The Fatigue Severity Scale. Arch Neurol 46: 1121-1123.
36. Kryger, M.H., Roth, T. and Dement, W. (eds) ( 2005). “Psychological and Behavioral Treatments. Sleep Hygiene Education”, Principles and Practice of Sleep Medicine, 4th edn, W.B. Saunders: Maryland Heights, th|ednWB
37. Kumar, R. ( 2008) Approved and investigational uses of modafinil. Drugs 68: 1803-1839.
38. Mannerkorpi, K. and Henriksson, C. ( 2007) Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Practice Res Clin Rheumatol 21: 513-534.
39. Mease, P.J., Arnold, L.M., Crofford, L.J., Williams, D.A., Russell, I.J., Humphrey, L. et al. (2008) Identifying the clinical domains of fibromyalgia: contributions from clinician and patients Delphi exercises. Arthritis Rheum 59: 952-960.
40. Mease, P.J., Clauw, D.J., Gendreau, R.M., Rao, S.G., Kranzler, J., Chen, W. et al. (2009) The Efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36: 398-409.
41. Middleton, G.D., McFarlin, J.E. and Lipsky, P.E. ( 1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37: 1181-1188.
42. Moldofsky, H. ( 1975) Musculosketal symptoms and non-REM sleep disturbance in patients with fibrositis syndrome and healthy subjects. Psychosom Med 37: 341-351.
43. Moldofsky, H. ( 1976) Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 38: 35-44.
44. Moldofsky, H. ( 2008) The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectrums 13(Suppl 5): 22-26.
45. Moldofsky, H. and Lue, F.A. ( 1980) The relationship of alpha and delta EEG frequencies to pain and mood in ‘fibrositis’ patients treated with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol 50: 71-80.
46. Morgenthaler, T.I., Kapur, V.K., Brown, T., Swick, T.J., Alessi, C., Aurora, R.N. et al. (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 29: 1415-1419.
47. Netzer, N.C., Stoohs, R.A., Netzer, C.M., Clark, K. and Strohl, K.P. ( 1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131: 485-491.
48. Neumann, L. and Buskila, D. ( 2003) Epidemiology of fibromyalgia. Curr Pain Headache Rep 7: 362-368.
49. Nishishinya, B., Urrutia, G., Walitt, B., Rodriguez, A., Bonfill, X., Alegre, C. et al. (2008) Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) 47: 1741-1746.
50. Ormseth, M.J., Eyler, A.E., Hammonds, C.L. and Boomershine, C.S. (2010) Milnacipran for the management of fibromyalgia syndrome. J Pain Research 3: 15-24.
51. Pachas, W.N. ( 2003) Modafinil for fatigue of fibromyalgia. J Clin Rheum 9: 282-285.
52. Pfizer Inc. (2009). Lyrica prescribing information. Available at: http://www.pfizer.com/files/products/uspi_lyrica.pdf (accessed 14 April 2010).
53. PriCara (2010). Nucynta prescribing information. Available at: http://www.nucynta.com/nucynta/assets/Nucynta-PI.pdf (accessed 14 April 2010).
54. Ratcliffe, G.E. ( 2008) Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective. Clin J Pain 24: 204-210.
55. Rooks, D.S., Gautam, S., Romeling, M., Cross, M.L., Stratigakis, D., Evans, B. et al. (2007) Group exercise, education, and combination self-management in women with fibromyalgia. Arch Intern Med 167: 2192-2200.
56. Rostain, A.L. ( 2008) Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med 120: 27-38.
57. Russell, I.J. and Larson, A. A (2009) Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am 35: 421-435.
58. Russell, I.J., Mease, P.J., Smith, T.R., Kajdasz, D.K., Wohlreich, M.M., Detke, M.J. et al. (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136: 432-444.
59. Russell, I.J., Vaeroy, H., Javors, M. and Nyberg, F. ( 1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35: 550-556.
60. Saletu, B., Prause, W., Anderer, P., Mandl, M., Aigner, M., Mikova, O. et al. (2005) Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 × 7 and the Siesta database. Neuropsychobiology 51: 148-163.
61. Samborski, W., Lezanska-Szpera, M. and Rybakowski, J.K. ( 2005) Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 37: 168-70.
62. Sayar, K., Aksu, G., Ak, I. and Tosun, M. ( 2003) Venlafaxine treatment of fibromyalgia. Ann Pharmacol 11: 1561-1565.
63. Schaller, J.L. and Behar, D. ( 2001) Modafinil in fibromyalgia treatment. J Neuropsych Clin Neurosci 13: 530-531.
64. Scharf, M.B., Baumann, M. and Berkowitz, D.V. ( 2003) The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheum 30: 1070-1074.
65. Scholz, B.A., Hammonds, C.L. and Boomershine, C.S. (2009) Duloxetine for the management of fibromyalgia syndrome. J Pain Research 2: 1-10.
66. Schwartz, T.L., Rayancha, S., Rashid, A., Chlebowksi, S., Chilton, M. and Morell, M. ( 2007) Modafinil treatment for fatigue associated with fibromyalgia. J Clin Rheum 13: 52.
67. See, S. and Ginzburg, R. ( 2008) Choosing a skeletal muscle relaxant. Am Fam Phys 78: 365-370.
68. Silverman, S., Dukes, E.M., Johnson, S.S., Brandenburg, N.A., Sadosky, A. and Huse, D.M. (2009) The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin 25: 829-840.
69. Simpson, D.A. ( 2001) Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 3: 53-62.
70. Slotkoff, A.T., Radulovic, D.A. and Clauw, D.J. ( 1997) The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheum 26: 364-367.
71. Soldatos, C.R., Dikeos, D.G. and Paparrigopoulos, T.J. ( 2000) Athens Insomnia Scale. J Psychosomatic Res 48: 555-560.
72. Spitzer, R.L., Kroenke, K., Williams, J.B.W. and Lowe, B. ( 2006) A brief measure for assessing generalized anxiety disorder. Arch Intern Med 166: 1092-1097.
73. Thieme, K. and Gracely, R.H. (2009) Are psychological treatments effective for fibromyalgia pain? Curr Rheumatol Rep 11: 443-450.
74. Tofferi, J.K., Jackson, J.L. and O'Malley, P.G. ( 2004) Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 51: 9-13.
75. Uceyler, N. ( 2008) A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum 59: 1279-1298.
76. Vaeroy, H., Helle, R., Forre, O., Kass, E. and Terenius, L. ( 1988) Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia. Pain 32: 21-26.
77. Vitton, O., Gendreau, M., Gendreau, J., Kranzler, J. and Rao, S.G. ( 2004) A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol Clin Exp 19: S27-S35.
78. Wallace, D.J. and Gotto, J. ( 2008) Hypothesis: bipolar illness with complaints of chronic musculoskeletal pain is a form of pseudofibromyalgia. Semin Arthritis Rheum 37: 256-259.
79. Walters, A.S. ( 1995) Toward a better definition of the restless legs syndrome. Mov Disord 10: 634-642.
80. White, K.P., Nielson, W.R., Harth, M., Ostbye, T. and Speechley, M. ( 2002) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheum 29: 588-594.
81. Wolfe, F. ( 2004) Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. J Rheum 31: 1896-1902.
82. Wolfe, F., Clauw, D.J., Fitzcharles, M., Goldenberg, D.L., Katz, R.S., Mease, P. et al. (2010) The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arth Care Res 62 (5): 600-601.
83. Wolfe, F., Hawley, D.J., Goldenberg, D.L., Russell, I.J., Buskila, D. and Neumann, L. ( 2000) The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM health assessment questionnaire. J Rheum 27: 1989-1999.
84. Wolfe, F. and Michaud, K. ( 2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheum 31: 695-700.
85. Wolfe, F., Ross, K., Anderson, J., Russell, I.J. and Hebert, L. ( 1995) The prevalence and characteristics of fibromyalgia in the general population. Arth Rheum 38: 19-28.
86. Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L. et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arth Rheum 33: 160-172.
87. Wolfe, F., Zhao, S. and Lane, N. ( 2001) Preference for nonsteroidal anti-inflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 44: 2451-2455.
88. Young, J.L. and Redmond, J.C. ( 2007) Fibromyalgia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: a case study. Psychopharmacol Bull 40: 118-126.
89. Yunus, M.B. and Aldag, J.C. ( 1996) Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 312: 1339.
90. Zachrisson, O., Regland, B., Jahreskog, M., Kron, M. and Gottfries, C.G. ( 2002) A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res 52: 501-509.